Roseann S. Gammal
MCPHS University(US)Massachusetts College of Pharmacy and Health Sciences(US)
Publications by Year
Research Areas
Pharmacogenetics and Drug Metabolism, Pharmaceutical studies and practices, BRCA gene mutations in cancer, Ethics in Clinical Research, Pharmacological Effects and Toxicity Studies
Most-Cited Works
- → Standardizing CYP2D6 Genotype to Phenotype Translation: Consensus Recommendations from the Clinical Pharmacogenetics Implementation Consortium and Dutch Pharmacogenetics Working Group(2019)507 cited
- → The Clinical Pharmacogenetics Implementation Consortium: 10 Years Later(2019)319 cited
- → Clinical Pharmacogenetics Implementation Consortium Guideline for HLA Genotype and Use of Carbamazepine and Oxcarbazepine: 2017 Update(2018)290 cited
- → Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 and Proton Pump Inhibitor Dosing(2020)284 cited
- → Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2B6 and Efavirenz‐Containing Antiretroviral Therapy(2019)173 cited
- → Pharmacogenetics for Safe Codeine Use in Sickle Cell Disease(2016)89 cited
- → Evidence and resources to implement pharmacogenetic knowledge for precision medicine(2016)89 cited
- → Precision pharmacotherapy: Integrating pharmacogenomics into clinical pharmacy practice(2019)81 cited
- → Expanded Clinical Pharmacogenetics Implementation Consortium Guideline for Medication Use in the Context of G6PD Genotype(2022)53 cited
- → Pharmacists Leading the Way to Precision Medicine: Updates to the Core Pharmacist Competencies in Genomics(2021)53 cited